Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$15.0 - $22.17 $735 - $1,086
-49 Reduced 43.36%
64 $1,000
Q2 2023

Aug 09, 2023

SELL
$21.6 - $30.69 $1,080 - $1,534
-50 Reduced 30.67%
113 $2,000
Q1 2023

Apr 20, 2023

SELL
$23.07 - $32.77 $322 - $458
-14 Reduced 7.91%
163 $5,000
Q4 2022

Feb 10, 2023

SELL
$25.29 - $35.48 $581 - $816
-23 Reduced 11.5%
177 $4,000
Q3 2022

Oct 17, 2022

SELL
$24.0 - $33.42 $360 - $501
-15 Reduced 6.98%
200 $6,000
Q2 2022

Aug 02, 2022

BUY
$24.78 - $33.36 $5,327 - $7,172
215 New
215 $5,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.